|
biomedicina slovenica |
pr=Cameron : 14
-
Schedel Michaela; Frei Remo; Bieli Christian; Cameron Lisa; Adamski Jerzy; Lauener Roger; Kabesch Michael
An IgE-associated polymorphism in STAT6 alters NF-kappaB binding, STAT6 promoter activity, and mRNA expression
2009 ►
-
Cardoso F; Costa A; Norton L; Cameron D; Čufer T; Fallowfield L; Francis P; Gligorov J; Kyriakides S; Lin N
1st International consensus guidelines for advanced breast cancer (ABC 1)
2012 ►
-
Paridaens Robert J; Dirix LucY; Beex Louk V; Nooij Marianne; Cameron David A; Čufer Tanja; Piccart Martine J; Bogaerts Jan; Therasse Patrick
Phase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: the European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group
2008 ►
-
Pajk Bojana; Čufer Tanja; Canney Peter; Ellis Paul; Cameron David; Blot Emmanuel; Vermorken Jan; Coleman Robert; Marreaud Sandrine; Bogaerts Jan
Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from EORTC 10001 randomized phase II trial
2008 ►
-
Zielinski Christoph C.; Awada Ahmad; Cameron David A.; Čufer Tanja; Martin Miguel; Aapro Matti S.
The impact of new European organisation for research and treatment of cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients
2008 ►
-
Paridaens R; Therasse P; Dirix L; Beex L; Piccart M; Cameron D; Čufer T; Roozendaal K; Nooij M; Mattiacci M-R
First line hormonal treatment (HT) for metastatic breast cancer (MBC) with exemestane (E) or tamoxifen (T) in postmenopausal patients (pts) - A randomized phase III trial of the EORTC breast group
2004 ►
-
Atalay G; Dirix L; Biganzoli L; Beex L; Nooij M; Cameron D; Lohrisch C; Čufer T; Lobelle JP; Mattiaci MR
The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'
2004 ►
-
Paridaens R; Therasse P; Dirix L; Beex L; Piccart MJ; Cameron D; Čufer T; Roozendael K; Nooy M; Mattiacci MR
First results of a randomized phase III trial comparing exemestane versus tamoxifen as first-line hormone therapy (HT) for postmenopausal women with metastatic breast cancer (MBC) - EORTC 10951 in collaboration with the exemestane working group and NCIC clinical trials group
2004 ►
-
Cameron Peter J; Giudici Michael; Gareth A; Kantor William M; Klin Mikhail; Marušič Dragan; Nowitz Lewis A
Transitive permutation groups without semiregular subgroups
2002 ►
-
Paridaens R; Dirix L; Lohrisch C; Beex L; Nooij M; Cameron D; Biganzoli L; Čufer T; Duchateau L; Hamilton A; Lobelle JP; Piccart M
Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer
2003 ►
-
Dirix L; Piccart MJ; Lohrisch C; Beex L; Nooij M; Cameron D; Biganzoli L; Čufer T; Yague C; Duchateau L
Efficacy of and tolerance to Exemestane (E) versus Tamoxifen (T) in 1st line hormone therapy (HT) of postmenopausal metastatic breast cancer (MBC) patients (pts): a European orgnisation for the research and treatment of cancer (EORTC breast group) phase II trial with Pharmacia and Upjohn
2001 ►
-
Lohrisch C; Paridaens R; Dirix LY; Beex L; Nooij M; Cameron D; Biganzoli L; Čufer T; Yague C; Duchateau L
Adverse impact on serum lipids of the irreversible aromatase inactivator Aromasin (Exemestane (E)) in 1st line treatment of metastatic breast cancer (MBC): companion study to a European organization of research and treatment of cancer (Breast group) trial with Pharmacias' Upjohn
2001 ►
-
Cameron NG; Birks HJB; Jones JV; Berge F; Catalan J; Flower RJ; Garcia J; Kawecka B; Koinig KA; Šiško M; et al ;
Surface-sediment and epilithic diatom pH calibration sets for remote European mountain lakes (AL:PE project) and their comparison with the surface waters acidification programme (SWAP) calibration set
1999 ►
-
Schreiner LJ; Cameron IG; Funduk N; Miljković L; Pintar MM; Kydon DN
Proton NMR spin grouping and exchange in dentin
1991 ►
New search
Comments
Top of page
Institute for Biostatistics and Medical Informatics